ClinicalTrials.Veeva

Menu

Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients

Northwell Health logo

Northwell Health

Status

Completed

Conditions

ESRD

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The investigators are studying the correlation between Hba1c and the mean plasma glucose in diabetic hemodialysis patients.We are reviewing if HbA1c is a good clinical tool to assess glycemic control over a 3 months duration in hemodialysis patients

Full description

The Hb turnover in hemodialysis population is higher than the general population leading to a general believe that HbA1c tend to underestimate mean plasma glucose.

The investigators are trying to define the correlation between mean plasma glucose and HbA1c in the hemodialysis population and trying to study the factors that could affect this correlation (dose of erythropoetin, ret count..) We are trying to see if HbA1c is a better tool to assess glycemic control over 1 month than glycemic control over 3 month.

This clinicaly will translate in obtaining HbA1c more frequently in hemodialysis patients to assess their glycemic control.

Enrollment

159 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age>18
  • Hemodialysis and diabetic
  • Lab data are available for more than 6 months

Exclusion criteria

  • Lab data not available

Trial design

159 participants in 1 patient group

diabetic hemodialysis
Description:
all patient diabetic and on hemodialysis were involved if they are on hemodialysis for more than 3 months

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems